Your Article Summary
Efficacy of behavioural interventions in managing atypical antipsychotic weight gain
Obesity Reviews, 07/02/09
Gabriele JM et al. - Atypical antipsychotic treatment is associated with weight gain and increased metabolic risk. The information will be useful in determining what types of interventions are both effective and practical for delivery in health care or community mental health settings.
Related Articles
Use Of Antipsychotic Medications By Children And Adolescents Associated With Significant Weight Gain
Internet Source, 10/29/09
Relevance Score: 81%
Antipsychotics cause rapid weight gain in youth
Reuters, 10/28/09
Relevance Score: 80%
Metabolic and Cardiac Side Effects of Second-generation Antipsychotics: What Every Clinician Should Know
Journal of Pharmacy Practice, 11/05/09
Relevance Score: 79%
Cardiometabolic Risk of Second-Generation Antipsychotic Medications During First-Time Use in Children and Adolescents
JAMA, 10/29/09
Relevance Score: 79%
Aripiprazole versus other atypical antipsychotics for schizophrenia
Cochrane Reviews, 10/21/09
Relevance Score: 78%
Today in Metabolism and Growth...keeping you current
Receive free subspecialty "5-minute updates" via email
Prediction of Adult Height Based on Automated Determination of Bone Age
Journal of Clinical Endocrinology and Metabolism, 11/25/09
Assessment of Circulating Sex Steroid Levels in Prepubertal and Pubertal Boys and Girls by a Novel Ultrasensitive Gas Chromatography-Tandem Mass Spectrometry Method
Journal of Clinical Endocrinology and Metabolism, 11/25/09
Effects of Olanzapine and Haloperidol on the Metabolic Status of Healthy Men
Journal of Clinical Endocrinology and Metabolism, 11/25/09
Today in Obesity...keeping you current
Receive free subspecialty "5-minute updates" via email
Davalintide (AC2307), a novel amylin-mimetic peptide: enhanced pharmacological properties over native amylin to reduce food intake and body weight
International Journal of Obesity, 11/25/09
The prognostic impact of general and abdominal obesity in peripheral arterial disease
International Journal of Obesity, 11/25/09
Low Levels of Plasma Agmatine in the Metabolic Syndrome
Metabolic Syndrome and Related Disorders, 11/25/09
Today in Pharmacology/kinetics...keeping you current
Receive free subspecialty "5-minute updates" via email
Effects of metformin with or without supplementation with folate on homocysteine levels and vascular endothelium of women with polycystic ovary syndrome
Diabetes Care, 11/25/09
Davalintide (AC2307), a novel amylin-mimetic peptide: enhanced pharmacological properties over native amylin to reduce food intake and body weight
International Journal of Obesity, 11/25/09
Assessment of Regional Changes in Skeletal Metabolism Following 3 and 18 Months of Teriparatide Treatment
Journal of Bone and Mineral Research, 11/25/09

See Latest Articles